Life Sciences

Practices

• Corporate
  Band 1

  for US (Nationwide), California, Massachusetts and UK Life Sciences – Chambers, 2023

  #1

  for healthcare and life sciences IPOs since 2016 – Deal Point Data, 2024

  #1

  VC firm for pharma and biotech deals – PitchBook, 2023

  Top 2

  law firm for US life sciences M&A and venture capital – Mergermarket and PitchBook, 2023

  40+

  dedicated, international professionals across the US, Europe and Asia exclusively focused on corporate partnering, licensing, M&A and other commercial transactions specific to life sciences companies

  Tier 1

  for Corporate, Licensing & Collaboration, Venture Capital, Mergers & Acquisitions, Patent Strategy & Management, and Patent Prosecution – LMG Life Sciences Americas, 2023 Life Sciences Practice Group of the Year – Law360, 2023

  Read more
• Litigation
  100+

  venues argued before – including state, federal and international courts, arbitral forums, and administrative bodies

  Five

  fellows of the American College of Trial Lawyers and 20+ former assistant US attorneys and Department of Justice lawyers within our team

  Decades

  of experience resolving high-stakes disputes in the pharmaceutical, biotechnology and medical device spaces across key jurisdictions

  Experience in internal investigations and all aspects of white-collar and securities defense, including complex government investigations and enforcement actions for life sciences and healthcare companies

  Defended more life sciences companies in shareholder litigation filed over the past 10 years than any other firm

  History of achieving groundbreaking victories on behalf of life sciences clients in the US Supreme Court and California Supreme Court, as well as complete wins in commercially significant drug ownership and licensing disputes

  Regularly defend False Claims Act actions arising from allegations of billing/coding misconduct, patient safety and research misconduct, manufacturing deficiencies, other Federal Food, Drug, and Cosmetic Act violations, drug pricing misconduct, federal and state anti-kickback law violations, and other relevant fraud and abuse laws led by local, state, and federal civil and criminal government enforcers

  Read more
• Regulatory
  Provide regulatory counseling and advice on US Food and Drug Administration (FDA), fraud and abuse, corporate compliance, contractual relationships, sunshine laws, reimbursement, government program price reporting, healthcare data privacy, licensure and accreditation, health reform counseling, regulatory due diligences, Medicines and Healthcare products Regulatory Agency (MHRA) and CE marking

  Multidisciplinary team of top lawyers advises all players in the evolving ecosystem, including payors, providers, life sciences companies, healthtech companies and investors, providing counseling on privacy and data protection, government contracts, and government analytics

  History of leveraging our experience as connectors to the ecosystem to counsel clients on launching innovative products and services

  Represent healthcare clients in connection with federal and state government investigations, inquiries, settlements and voluntary disclosures, leveraging subject matter knowledge and litigation and negotiation experience

  Frequently contribute to groundbreaking regulatory topics at leading industry events, via editorial boards, and in relevant media and publications

  Provide comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turn

  Read more
• Intellectual Property
  100+

  life sciences patent team members across the US and UK

  1,000+

  IP due diligence reviews in life sciences deals/transactions

  46,000+

  patents currently under our management worldwide and one of the more active IP litigation practices in the US, with 500+ cases in the last five years

  Record of securing complete wins in commercially significant drug ownership and licensing disputes

  Decades

  of experience litigating Hatch-Waxman matters for branded pharmaceutical companies

  Provide guidance on selecting, clearing, protecting and obtaining regulatory approval for drug and device names with insight from our branding team

  Read more